NCT04133415View on ClinicalTrials.gov

Palliative Lattice Stereotactic Body Radiotherapy (SBRT)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2019

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
CancerPalliative Radiotherapy
Interventions
RADIATION

Lattice stereotactic body radiation therapy

-As long as radiotherapy fields do not overlap, treatment of up to 4 other tumor sites are allowed

PROCEDURE

Peripheral blood

-Before treatment, immediately after radiotherapy completion, 14 days after radiotherapy, and 30 days after radiotherapy

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT04133415 - Palliative Lattice Stereotactic Body Radiotherapy (SBRT) | Biotech Hunter | Biotech Hunter